| For: | Abdalla MMI. Insulin resistance as the molecular link between diabetes and Alzheimer's disease. World J Diabetes 2024; 15(7): 1430-1447 [PMID: 39099819 DOI: 10.4239/wjd.v15.i7.1430] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i7/1430.htm |
| Number | Citing Articles |
| 1 |
Ju Wu, Jin Li, Xiaolan Qin, Weiping Chen. Association between diabetes mellitus and risk of Alzheimer’s disease: a meta-analysis and systematic review. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1736410
|
| 2 |
|
| 3 |
Fatemeh Nezamzadeh, Azin Masroor, Aylin Esmailkhani, Abed Zahedi Bialvaei. Exploring the complex interplay: insulin resistance and gut microbiome dysbiosis in multiple sclerosis. Neuroscience 2025; 582 doi: 10.1016/j.neuroscience.2025.07.024
|
| 4 |
Kenneth Maiese. Circadian Rhythm, Clock Genes, and Stroke. Current Neurovascular Research 2025; 21(4) doi: 10.2174/1567202622999241028121817
|
| 5 |
Alexandra M. Johnstone, Emiliano Albanese, Daniel R. Crabtree, Boushra Dalile, Stefanie Grabrucker, Jenna M. Gregory, Giuseppe Grosso, Adrian Holliday, Catherine Hughes, Catherine Itsiopoulos, John Mamo, Claire McEvoy, Phyo Kyaw Myint, Leticia Radin Pereira, David Vauzour, Mario Siervo. Consensus statement on exploring the Nexus between nutrition, brain health and dementia prevention. Nutrition & Metabolism 2025; 22(1) doi: 10.1186/s12986-025-00981-6
|
| 6 |
Rasoul Ebrahimi, Zahra Golzari, Mahsa Heidari-Foroozan, Abolfazl Khosravi, Samin Ghaheri Sharghi, Mobina Saleh, Shakiba Salarvandian, Khadijeh Esmaeilpour. Impaired Synaptic Plasticity Mechanisms in Alzheimer’s Disease. Metabolic Brain Disease 2025; 40(7) doi: 10.1007/s11011-025-01712-9
|
| 7 |
Kiran Marathe, Dhruv Sanjay Gupta, Kalyani Barve, Dhananjay Bodas. A critical appraisal of drug transport across the blood-brain barrier: Evaluation using new-age microfluidic technique. Brain Research Bulletin 2026; 234 doi: 10.1016/j.brainresbull.2025.111662
|
| 8 |
Hsuan-Yu Huang, Yu-Yin Huang, Chia-Lin Wu, Wei-Chien Huang, Chih-Ho Lai. Smog, sugar, and synapses: Unraveling the PM2.5-insulin resistance-Alzheimer’s disease axis. Redox Biology 2026; 90 doi: 10.1016/j.redox.2026.104031
|
| 9 |
Rahul Kumar, Ankita Devi, Anamika Sharma, Karadagatla Suman, Shovit Ranjan. Neurobiology of Type 2 Diabetes. 2026; doi: 10.1016/B978-0-443-32848-0.00022-4
|
| 10 |
Kenneth Maiese. Diabetes mellitus and glymphatic dysfunction: Roles for oxidative stress, mitochondria, circadian rhythm, artificial intelligence, and imaging. World Journal of Diabetes 2025; 16(1): 98948 doi: 10.4239/wjd.v16.i1.98948
|
| 11 |
Md Abubakar, Aditi Giri, Falguni Goel, Manshad Khan, Janmejay Gupta, Daksh Kumar, Monika Kaushik, Sachchida Nand Rai, Nitesh Kumar. Diabetes, Alzheimer's Disease Risk Factors, and the Cafeteria Diet: A Comprehensive Review. Current Neuropharmacology 2026; 24(4) doi: 10.2174/011570159X384737250626094315
|
| 12 |
Mona Mohamed Ibrahim Abdalla. Gut-liver axis in diabetes: Mechanisms and therapeutic opportunities. World Journal of Gastroenterology 2025; 31(29): 109090 doi: 10.3748/wjg.v31.i29.109090
|
| 13 |
John Cheung-Yuen Chan. Alzheimer's disease model explains Alzheimer’s disease incidences. Journal of Alzheimer's Disease Reports 2025; 9 doi: 10.1177/25424823251395616
|
| 14 |
Gunjan Adwani, Awanish Kumar. Diabetes and Alzheimer's Disease. 2026; doi: 10.1016/B978-0-443-40559-4.00007-6
|
| 15 |
Giulia Frank, Paola Gualtieri, Rossella Cianci, Mario Caldarelli, Roselisa Palma, Gemma Lou De Santis, Chiara Porfilio, Francesco Nicoletti, Giulia Bigioni, Laura Di Renzo. Body Composition and Alzheimer’s Disease: A Holistic Review. International Journal of Molecular Sciences 2024; 25(17) doi: 10.3390/ijms25179573
|
| 16 |
Ahmad Raza, Shafaq Saleem, Samar Imran, Sarah Rahman, Muhammad Haroon, Azeen Razzaq, Ahmad Hussain, Javed Iqbal, Brijesh Sathian. From metabolic dysregulation to neurodegenerative pathology: the role of hyperglycemia, oxidative stress, and blood-brain barrier breakdown in T2D-driven Alzheimer’s disease. Metabolic Brain Disease 2025; 40(7) doi: 10.1007/s11011-025-01700-z
|
| 17 |
Kenneth Maiese. Anxiety and Depression: Triggers for Cognitive Loss, Alzheimer's Disease, and Neurodegeneration. Current Neurovascular Research 2025; 22(1) doi: 10.2174/0115672026423887250627095817
|
| 18 |
Riddhi Upadhyay, Sneha Santhosh, R. Malathi, P. Saravana Kumari, S. Vijayanand, Murugan Sevanan. Brain Energy Metabolism in Alzheimers Disease - Part A. International Review of Neurobiology 2026; 186 doi: 10.1016/bs.irn.2026.01.010
|
| 19 |
Suman Manandhar, Prasada Chowdari Gurram, Anusha Govindula, Shama Prasada Kabekkodu, K Sreedhara Ranganath Pai. Voglibose Attenuates Amyloid Beta–Induced Memory Deficits in a Rodent Model: A Potential Alzheimer’s Therapy via Wnt Signaling Modulation. Molecular Neurobiology 2025; 62(9) doi: 10.1007/s12035-025-05047-5
|
| 20 |
Kenneth Maiese. Osteoarthritis and dementia: contrasting disorders driven by mutual pathways of autophagy, mTOR, GLP-1, AMPK, Wnt, and WISP1. Expert Review of Clinical Pharmacology 2026; 19(5) doi: 10.1080/17512433.2026.2671269
|
| 21 |
Dhriti P. Shah, Amee Krishnakumar. Diabetes and Alzheimer's Disease. 2026; doi: 10.1016/B978-0-443-40559-4.00014-3
|
| 22 |
Sandesh Kumar Pattanaik, Prajapati Manisha Anil, Sudipta Jena, Diptirani Rath. Interlinking diabetes and Alzheimer's disease: A pathway through medicinal plant-based treatments. Journal of Ethnopharmacology 2025; 351 doi: 10.1016/j.jep.2025.120092
|
| 23 |
Ankita Sharma, Aman Jyoti, Prasad Rasane, Jyoti Singh. Protecting vascular health: the role of flavonoids during pregnancy complications in mitigating the risk of vascular dementia later in life. Inflammopharmacology 2025; 33(6) doi: 10.1007/s10787-025-01788-w
|
| 24 |
Majid Tozihi, Alireza Nourazarian, Hadi Yousefi, Gholamreza Dehghan. Methylglyoxal-induced neuronal dysfunction: Linking diabetes to Alzheimer's disease through cytoskeletal disruption. European Journal of Pharmacology 2025; 998 doi: 10.1016/j.ejphar.2025.177526
|
| 25 |
Rasha E. Mostafa, Gihan F. Asaad. Bridging the gaps in alzheimer’s disease: a comprehensive review of current and emerging therapies. Inflammopharmacology 2026; 34(4) doi: 10.1007/s10787-026-02151-3
|
| 26 |
Laura Maria De Plano, Luigi Chiricosta, Simone D’Angiolini, Alessandra Saitta, Alessandra Trainito, Serena Silvestro, Sabrina Conoci, Salvatore Oddo, Antonella Caccamo. A phage displaying an Aβ-interacting peptide mitigates neurotoxicity and prevents Aβ-driven gene expression changes. Frontiers in Molecular Neuroscience 2025; 18 doi: 10.3389/fnmol.2025.1716626
|
| 27 |
Zhang Heng, Yamato Yotsuya, Tomoki Omachi, Yasushi Hasegawa. Nacre extract improves insulin resistance and cognitive functions in diabetic mice. Asian Pacific Journal of Tropical Biomedicine 2025; 15(11) doi: 10.4103/apjtb.apjtb_458_25
|
| 28 |
Himanshu Vishwakarma, Abhishek Chauhan, Loveleen Kaur, Ankit Awasthi. Nanotechnology-enabled targeting strategies for neurodegenerative disorders: role of functionalized nanoparticles. Journal of Pharmacy and Pharmacology 2026; 78(6) doi: 10.1093/jpp/rgag060
|
| 29 |
Shivani Chib, Bhaskar Jyoti Dutta, Rishabh Chalotra, Md Abubakar, Puneet Kumar, Thakur Gurjeet Singh, Randhir Singh. Role of Flavonoids in Mitigating the Pathological Complexities and Treatment Hurdles in Alzheimer's Disease. Phytotherapy Research 2025; 39(2) doi: 10.1002/ptr.8406
|
| 30 |
Bo Wang, Yuping Shao, Rongxiang Liang. Exercise Suppresses Insulin Resistance: A Potential Mechanism for Improving the Interaction Between Type 2 Diabetes and Alzheimer’s Disease. Journal of Integrative Neuroscience 2026; 25(1) doi: 10.31083/JIN44389
|
| 31 |
Qiwen Cheng, Jennifer Nolz, Timothy Karr, Nicole Dorn, Benjamin Readhead, Rosa Krajmalnik‐Brown, Diego Mastroeni. Gut proteome and microbiome alterations: Analysis of transverse colon samples from pathologically confirmed Alzheimer's disease patients. Alzheimer's & Dementia 2026; 22(1) doi: 10.1002/alz.71021
|
| 32 |
Kenneth Maiese. Agitation, Alzheimer’s disease, and autophagy: mechanistic insights into aging pathways, gut microbiome, and artificial intelligence. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1846280
|
| 33 |
Faisal Alzenaidi, Osama Aldoweesh, Salman Alghofaili, Abdulaziz Fadel, Razan Ali Awad Lasloom, Dhay Alharbi, Faris Almalki, Atheer Ahmad Alkhairi, Maram Alharbi, Norah Ahmed Alhamdan, Ahmed Y. Azzam. Selective serotonin reuptake inhibitors and glucose metabolism in Alzheimer's disease and related dementias: A systematic review and meta-analysis of brain metabolic and adverse event data. Metabolism Open 2025; 27 doi: 10.1016/j.metop.2025.100389
|
| 34 |
Archana Mishra, Debasish Hota. Diabetes and Neurodegeneration. 2026; doi: 10.1016/B978-0-443-33355-2.00008-6
|
| 35 |
Mengfan Xu, Jia Wang, Yuqing She, Junbo He, Mei Yu, Zhenwen Zhang, Penghua Fang. The role of galanin/GALR2 signaling in the link between type 2 diabetes and Alzheimer's disease. Neuropeptides 2026; 116 doi: 10.1016/j.npep.2026.102586
|
| 36 |
Tanya Gupta, Shivam Kumar, Thakur Gurjeet Singh, Randhir Singh. The metabolic roots of memory loss: interlinking the Diabetes-Alzheimer’s hypothesis. Metabolic Brain Disease 2026; 41(1) doi: 10.1007/s11011-026-01824-w
|
| 37 |
Abhishek Mishra, Bhabani Sankar Satapathy, Pratap Kumar Sahu. Solid lipid nanoparticles enhance piracetam’s neuroprotective action in streptozotocin-induced cognitive dysfunction. Discover Nano 2026; 21(1) doi: 10.1186/s11671-026-04528-3
|
| 38 |
Asha Abraham, Vijayalakshmi Gangadhara, Pallavi Baliga. Diabetes and Alzheimer's Disease. 2026; doi: 10.1016/B978-0-443-40559-4.00008-8
|
| 39 |
Kyle W. Cuklanz, Abigail Stein, Virginie-Anne Chouinard, Dost Ongur, Fei Du. Redox therapy for neuropsychiatric disorders: Molecular mechanisms and biomarker development. Science Advances 2026; 12(8) doi: 10.1126/sciadv.aea9014
|
| 40 |
Kenneth Maiese. Wnt Signaling, Musculoskeletal Disease, and the Onset of Dementia and Alzheimer's Disease. Current Neurovascular Research 2025; 21(5) doi: 10.2174/1567202622999241211154331
|
| 41 |
Huimin Cao, Yuying Zhao, Ziyi Chen, Xiaoya Zou, Xinyi Du, Li Yi, Yu Ai, Hongzhou Zuo, Oumei Cheng, Julia Gallagher, Alice S. Chen-Plotkin, Nabila Dahodwala, James F. Morley, Andrew D. Siderowf, Allison W. Willis, Daniel Weintraub, Eugenia Mamikonyan, Sharon X. Xie, Caroline Gochanour, Chelsea Caspell-Garcia, Christopher S. Coffey, Roseanne D. Dobkin, Dag Aarsland, Roy N. Alcalay, Matthew J. Barrett, Lana M. Chahine, Jamie L. Eberling, Alberto J. Espay, James B. Leverenz, Irene Litvan, Irene H. Richard, Liana S. Rosenthal, Tatyana Simuni, Michele K. York. Triglyceride-glucose index predicts cognitive decline and striatal dopamine deficiency in Parkinson disease in two cohorts. npj Parkinson's Disease 2025; 11(1) doi: 10.1038/s41531-025-01100-1
|
| 42 |
Monika Pliszka, Leszek Szablewski. Insulin Signaling in Alzheimer’s Disease: Association with Brain Insulin Resistance. International Journal of Molecular Sciences 2026; 27(3) doi: 10.3390/ijms27031222
|
| 43 |
Muhammad Sohail Khan, Ashfaq Ahmad, Somayyeh Nasiripour, Jean C. Bopassa. Type 2 Diabetes and Alzheimer’s Disease: Molecular Mechanisms and Therapeutic Insights with a Focus on Anthocyanin. Journal of Dementia and Alzheimer's Disease 2026; 3(1) doi: 10.3390/jdad3010005
|
| 44 |
Ramesh Kordi, Ted J. Andrews, Mark D. Hicar. Infections, genetics, and Alzheimer's disease: Exploring the pathogenic factors for innovative therapies. Virology 2025; 607 doi: 10.1016/j.virol.2025.110523
|
| 45 |
Kenneth Maiese. Cannabis and Cannabidiol: Pioneering Treatment for the Nervous System with Alzheimer's Disease and Peripheral Organ Involvement with Nonalcoholic Fatty Liver Disease (NAFLD). Current Neurovascular Research 2025; 22(2) doi: 10.2174/0115672026446790250918074353
|
| 46 |
Arantxa Rodriguez-Casado, Mª Isabel Alvarez, Jose-Joaquin Merino, Adolfo Toledano-Díaz, Adolfo Toledano. Relationship between Alzheimer's Disease and Type 2 Diabetes: Critical Review On Cellular and Molecular Common Pathogenic Mechanisms. Current Alzheimer Research 2025; 22(2) doi: 10.2174/0115672050375461250325074826
|
| 47 |
Reham Hassan Mekky, Mareena M. Thabet, Omayma El-Gindi, Mohamed Adel Said, Safwat A. Ahmed, Reda F. A. Abdelhameed. Comparative phytochemical and biological evaluation of Egyptian Swinglea glutinosa stems and leaves. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-00427-2
|
| 48 |
Ayse Nur Hazar-Yavuz, Humeysa Kiyak-Kirmaci, Hanife Serife Aktas, Ozlem Tugce Cilingir-Kaya, Levent Kabasakal, Hatice Kubra Elcioglu. Effects of thymoquinone on cognitive functions and kynurenine metabolites induced in rats by streptozotocin/nicotinamide. European Journal of Pharmacology 2026; 1011 doi: 10.1016/j.ejphar.2025.178383
|
| 49 |
Kannayiram Alagiakrishnan, Tyler Halverson. Role of Peripheral and Central Insulin Resistance in Neuropsychiatric Disorders. Journal of Clinical Medicine 2024; 13(21) doi: 10.3390/jcm13216607
|
| 50 |
Tara J. Jewell, Michelle Minehan, Jackson Williams, Nathan M. D’Cunha. Precision Nutrition for Dementia: Exploring the Potential in Mitigating Dementia Progression. Journal of Dementia and Alzheimer's Disease 2025; 2(3) doi: 10.3390/jdad2030028
|
| 51 |
Anery Shah, Gaurav Doshi. Insulin resistance and SIRT1 dysregulation in neurodegenerative diseases. Ageing Research Reviews 2026; 117 doi: 10.1016/j.arr.2026.103072
|
| 52 |
Pushpa Yadav, Priya Singh. Diabetes and Alzheimer's Disease. 2026; doi: 10.1016/B978-0-443-40559-4.00004-0
|
| 53 |
Kenneth Maiese. Biological gases, oxidative stress, artificial intelligence, and machine learning for neurodegeneration and metabolic disorders. Medical Gas Research 2025; 15(1) doi: 10.4103/mgr.MEDGASRES-D-24-00059
|
| 54 |
Eunji Lee, Jiyun Hwang, Dong Woo Kim, Byung Yoon Choi, Hee-Joon Bae, Seung Hyun Won, Young Ho Park, SangYun Kim. Association between high carbohydrate to dietary fiber ratio and risk of dementia in older adults: analysis from the UK biobank. BMC Neurology 2025; 26(1) doi: 10.1186/s12883-025-04583-w
|
| 55 |
Tanisha Tabassum Sayka Khan, Chun Yuen Jerry Wong, Zara Sheikh, Ali Fathi, Simin Maleknia, Farshad Oveissi, Terence Abrams, Will Knox, Julia van der Hoven, Abi Antonito, Michael Murray, Maree Svolos, Julie Suman, Ole Tietz, Hui Xin Ong, Daniela Traini. Repurposing insulin for Alzheimer’s disease treatment: intranasal delivery of a thermoresponsive nanocarrier-based insulin formulation to the brain. Drug Delivery and Translational Research 2026; doi: 10.1007/s13346-026-02146-1
|
| 56 |
Daniela Dimitrova, Gabriela Kehayova, Simeonka Dimitrova, Stela Dragomanova. Marine-Derived Natural Substances with Anticholinesterase Activity. Marine Drugs 2025; 23(11) doi: 10.3390/md23110439
|
| 57 |
Atiyeh Kolouei, Mohammad Barati. Molecular interactions of diabetes medications with alzheimer’s related targets by molecular docking. Journal of Diabetes & Metabolic Disorders 2025; 24(2) doi: 10.1007/s40200-025-01747-w
|
| 58 |
Chieh Chen, Da-Ming Liao. A literature review on the relationship between diabetes and dementia. Tungs' Medical Journal 2026; doi: 10.4103/ETMJ.ETMJ-D-25-00032
|
| 59 |
Mona Mohamed Ibrahim Abdalla. Advancing diabetes management: Exploring pancreatic beta-cell restoration’s potential and challenges. World Journal of Gastroenterology 2024; 30(40): 4339-4353 doi: 10.3748/wjg.v30.i40.4339
|
| 60 |
Kai Chen, Yiqing Nong, Ying Liu, Ziming Ye. Insulin Resistance Across Cerebrovascular and Related Disorders: Mechanisms, Measurement, Genetics, and Clinical Implications. Neuropsychiatric Disease and Treatment 2026; doi: 10.2147/NDT.S575306
|